Immunotherapy Is Changing First-Line Treatment of Metastatic Renal-Cell Carcinoma

Autor Labriola, Matthew K., Batich, Kristen A., Zhu, Jason, McNamara, Megan A., Harrison, Michael R., Armstrong, Andrew J., George, Daniel J., Zhang, Tian
Vydáno v Clin Genitourin Cancer (2019)

Characterization of tumor mutation burden, PD-L1 and DNA repair genes to assess relationship to immune checkpoint inhibitors response in metastatic renal cell carcinoma

Autor Labriola, Matthew Kyle, Zhu, Jason, Gupta, Rajan, McCall, Shannon, Jackson, Jennifer, Kong, Eric F, White, James R, Cerqueira, Gustavo, Gerding, Kelly, Simmons, John K, George, Daniel, Zhang, Tian
Vydáno v J Immunother Cancer (2020)

LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types

Autor Brown, Landon C, Tucker, Matthew D, Sedhom, Ramy, Schwartz, Eric B, Zhu, Jason, Kao, Chester, Labriola, Matthew K, Gupta, Rajan T, Marin, Daniele, Wu, Yuan, Gupta, Santosh, Zhang, Tian, Harrison, Michael R, George, Daniel J, Alva, Ajjai, Antonarakis, Emmanuel S, Armstrong, Andrew J
Vydáno v J Immunother Cancer (2021)

Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients

Autor Zhang, Tian, Pabla, Sarabjot, Lenzo, Felicia L., Conroy, Jeffrey M., Nesline, Mary K., Glenn, Sean T., Papanicolau-Sengos, Antonios, Burgher, Blake, Giamo, Vincent, Andreas, Jonathan, Wang, Yirong, Bshara, Wiam, Madden, Katherine G., Shirai, Keisuke, Dragnev, Konstantin, Tafe, Laura J., Gupta, Rajan, Zhu, Jason, Labriola, Matthew, McCall, Shannon, George, Daniel J., Ghatalia, Pooja, Dayyani, Farshid, Edwards, Robert, Park, Michelle S, Singh, Rajbir, Jacob, Robin, George, Saby, Xu, Bo, Zibelman, Matthew, Kurzrock, Razelle, Morrison, Carl
Vydáno v Oncoimmunology (2020)

Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors

Autor Conroy, Jeffrey M., Pabla, Sarabjot, Nesline, Mary K., Glenn, Sean T., Papanicolau-Sengos, Antonios, Burgher, Blake, Andreas, Jonathan, Giamo, Vincent, Wang, Yirong, Lenzo, Felicia L., Bshara, Wiam, Khalil, Maya, Dy, Grace K., Madden, Katherine G., Shirai, Keisuke, Dragnev, Konstantin, Tafe, Laura J., Zhu, Jason, Labriola, Matthew, Marin, Daniele, McCall, Shannon J., Clarke, Jeffrey, George, Daniel J., Zhang, Tian, Zibelman, Matthew, Ghatalia, Pooja, Araujo-Fernandez, Isabel, de la Cruz-Merino, Luis, Singavi, Arun, George, Ben, MacKinnon, Alexander C., Thompson, Jonathan, Singh, Rajbir, Jacob, Robin, Kasuganti, Deepa, Shah, Neel, Day, Roger, Galluzzi, Lorenzo, Gardner, Mark, Morrison, Carl
Vydáno v J Immunother Cancer (2019)

Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients

Autor Pabla, Sarabjot, Conroy, Jeffrey M., Nesline, Mary K., Glenn, Sean T., Papanicolau-Sengos, Antonios, Burgher, Blake, Hagen, Jacob, Giamo, Vincent, Andreas, Jonathan, Lenzo, Felicia L., Yirong, Wang, Dy, Grace K., Yau, Edwin, Early, Amy, Chen, Hongbin, Bshara, Wiam, Madden, Katherine G., Shirai, Keisuke, Dragnev, Konstantin, Tafe, Laura J., Marin, Daniele, Zhu, Jason, Clarke, Jeff, Labriola, Matthew, McCall, Shannon, Zhang, Tian, Zibelman, Matthew, Ghatalia, Pooja, Araujo-Fernandez, Isabel, Singavi, Arun, George, Ben, MacKinnon, Andrew Craig, Thompson, Jonathan, Singh, Rajbir, Jacob, Robin, Dressler, Lynn, Steciuk, Mark, Binns, Oliver, Kasuganti, Deepa, Shah, Neel, Ernstoff, Marc, Odunsi, Kunle, Kurzrock, Razelle, Gardner, Mark, Galluzzi, Lorenzo, Morrison, Carl
Vydáno v J Immunother Cancer (2019)